Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
Amsterdam - Delayed Quote EUR

Pharming Group N.V. (PHARM.AS)

Compare
0.8105
+0.0075
+(0.93%)
As of 2:25:33 PM GMT+1. Market Open.
Advanced Chart
Loading Chart for PHARM.AS
  • Previous Close 0.8030
  • Open 0.8120
  • Bid --
  • Ask --
  • Day's Range 0.8025 - 0.8300
  • 52 Week Range 0.6475 - 1.0660
  • Volume 7,812,919
  • Avg. Volume 5,793,544
  • Market Cap (intraday) 549.806M
  • Beta (5Y Monthly) 0.64
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date May 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 1.84

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.

www.pharming.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about Pharming Group N.V.

Recent News: PHARM.AS

View More
View More

Performance Overview: PHARM.AS

Trailing total returns as of 3/20/2025, which may include dividends or other distributions. Benchmark is AEX-Index (^AEX) .

YTD Return

PHARM.AS
12.38%
AEX-Index (^AEX)
4.52%

1-Year Return

PHARM.AS
21.46%
AEX-Index (^AEX)
6.71%

3-Year Return

PHARM.AS
10.45%
AEX-Index (^AEX)
28.19%

5-Year Return

PHARM.AS
4.55%
AEX-Index (^AEX)
112.58%

Compare To: PHARM.AS

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

PHARM.AS
Pharming Group N.V.
0.8105
+0.93%
Mkt Cap EUR 549.806M
Industry Biotechnology
GLPG.AS
Galapagos NV
23.86
-0.25%
Mkt Cap EUR 1.572B
Industry Biotechnology
CYAD.BR
Celyad Oncology SA
0.5770
-5.41%
Mkt Cap EUR 24.375M
Industry Biotechnology
BIOS.BR
BioSenic S.A.
0.0024
0.00%
Mkt Cap EUR 1.274M
Industry Biotechnology
VVY.AS
Vivoryon Therapeutics N.V.
1.9600
+0.51%
Mkt Cap EUR 51.091M
Industry Biotechnology
GLPG
Galapagos NV
26.00
-0.38%
Mkt Cap 1.713B
Industry Biotechnology
ONWD.BR
Onward Medical N.V.
4.6800
-0.43%
Mkt Cap EUR 208.94M
Industry Biotechnology
UCB.BR
UCB SA
179.90
-0.50%
Mkt Cap EUR 34.434B
Industry Biotechnology
IVA.PA
Inventiva S.A.
2.7700
0.00%
Mkt Cap EUR 262.262M
Industry Biotechnology
NRXPW
NRx Pharmaceuticals, Inc.
0.0880
-5.38%
Mkt Cap -
Industry Biotechnology
CELU
Celularity Inc.
1.7400
+4.19%
Mkt Cap 41.426M
Industry Biotechnology

Statistics: PHARM.AS

View More

Valuation Measures

As of 3/19/2025

  • Market Cap

    544.72M

  • Enterprise Value

    493.90M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.03

  • Price/Book (mrq)

    2.69

  • Enterprise Value/Revenue

    1.82

  • Enterprise Value/EBITDA

    30.83

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -3.71%

  • Return on Assets (ttm)

    -1.25%

  • Return on Equity (ttm)

    -5.01%

  • Revenue (ttm)

    297.2M

  • Net Income Avi to Common (ttm)

    -11.03M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    167.89M

  • Total Debt/Equity (mrq)

    50.62%

  • Levered Free Cash Flow (ttm)

    1.12M

View More

Research Analysis: PHARM.AS

View More
View More

People Also Watch

GLPG.AS Galapagos NV
23.86
-0.25%
 
BAMNB.AS Koninklijke BAM Groep nv
5.22
-1.60%
 
PNL.AS PostNL N.V.
0.9990
-0.79%
 
FUR.AS Fugro N.V.
14.38
-2.31%
 
AGN.AS Aegon Ltd.
6.06
-1.43%
 
AMG.AS AMG Critical Materials N.V.
17.17
-3.70%
 
BESI.AS BE Semiconductor Industries N.V.
107.15
-0.56%
 
ALFEN.AS Alfen N.V.
13.75
-1.26%
 
KPN.AS Koninklijke KPN N.V.
3.7830
-0.26%
 
TKWY.AS Just Eat Takeaway.com N.V.
19.48
-0.03%
 
ABN.AS ABN AMRO Bank N.V.
19.75
-2.13%
 
SBMO.AS SBM Offshore N.V.
20.22
-0.59%
 
AVTX.AS Avantium N.V.
1.5500
-0.90%
 
OCI.AS OCI N.V.
10.90
-1.04%
 
INGA.AS ING Groep N.V.
18.32
-2.54%
 
TWEKA.AS TKH Group N.V.
39.02
-1.76%